A Review on Liposomal Drug Delivery in Cancer Therapy

Author(s)	Ms. Asha Devi, Mr. Shivam Kaushik
Country	India
Abstract	A promising approach to cancer treatment, liposomal drug delivery systems provide better pharmacokinetics, more precise tumor targeting, and less systemic toxicity—the lipid bilayer spherical vesicles known as liposomes are both hydrophilic and hydrophobic. Due to the increased permeability and retention (EPR) effect, liposomes raise the concentration of anti-cancer medications in tumor tissues. Clinical approval has been granted to certain liposomal formulations, such as Doxorubicin, which are superior to non-liposomal forms. PEGylation and ligand attachment, two modifications to liposomal surfaces, have enhanced targeting and circulatory sustenance. Additionally, the tumor microenvironment can control drug release thanks to the combination of sensitive stimulation systems. Nevertheless, biological barriers, liposome stability, overcoming further biological obstacles, and bulk manufacturing optimization are still problems. Research and clinical work are needed to take full advantage of liposomal systems in cancer therapy.
Keywords	Liposomes, drug delivery, liposomal drugs, carcinoma.
Published In	Volume 7, Issue 4, July-August 2025
Published On	2025-07-18
DOI	https://doi.org/10.36948/ijfmr.2025.v07i04.49998
Short DOI	https://doi.org/g9tz29

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9687-828-838	editor@ijfmr.com

International Journal For Multidisciplinary Research